Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
Year: 2010
Type: article
Source: Thrombosis and Haemostasis
DOI: 10.1160/th10-05-0328
Institution: Bristol-Myers Squibb (United States)
Language: English
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Bristol-Myers Squibb, Pfizer
OpenAlex ID: W2103196751
